In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
Republicans were already getting serious about “debanking.” Now it’s an official priority of the Trump White House.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback